Seed and early-stage equity
Equity investment in a young company where product development, initial customer adoption and team formation are the primary milestones.
Start a conversation INVESTMENT AREA · 02 / 06
INNOVATION & GROWTH
Venture capital requires conviction about a specific problem, a differentiated solution and a credible route from early adoption to durable economics. The investment case must account for uncertainty, dilution and the possibility that additional capital will be needed before a business is self-sustaining.

THE INVESTMENT THESIS
We examine product quality, customer retention, distribution, gross margins, the pace of learning and the founders’ ability to recruit and adapt. Market size alone is not an investment thesis: adoption evidence, competitive differentiation and a realistic financing plan matter more than unsupported growth assumptions.
CAPITAL STRUCTURES
Financing terms evolve with a company’s maturity, evidence of product-market fit and funding needs. Ownership, dilution, governance and follow-on capacity should be considered together.
Equity investment in a young company where product development, initial customer adoption and team formation are the primary milestones.
Equity with negotiated economic and governance terms, assessed in the context of valuation, investor rights, future financing and alignment across the cap table.
Convertible notes or similar instruments may bridge a financing stage when maturity, conversion mechanics, priority and dilution outcomes are clearly understood.
DILIGENCE FRAMEWORK
Customer problem severity, product differentiation, willingness to pay, retention and repeatable adoption.
Gross margin, acquisition cost, payback, customer lifetime assumptions and the sensitivity of these measures as the company grows.
Founder capability, technical and commercial leadership, hiring priorities and the quality of decision-making under uncertainty.
Cash burn, milestone funding, future capital needs, cap-table dynamics and the consequences of a slower fundraising environment.
LONG-TERM OWNERSHIP
Patient capital can support product maturity, customer discovery, recruitment, reliable infrastructure and disciplined market entry. Progress is reviewed against defined milestones so that follow-on capital is tied to evidence, learning and improvement in the business rather than growth at any cost.
Venture investments can lose all or a substantial part of their value. Principal risks include product failure, slow customer adoption, technology obsolescence, competition, regulation, execution, dilution and dependence on future financing. Portfolio construction and position sizing must reflect this uncertainty.
INVESTMENT FRAMEWORK
A sector-specific framework for evaluating opportunities, structures, risks and long-term ownership considerations.
This is general investment analysis, not a record of Narion transactions or a statement of an active mandate. Any opportunity remains subject to appropriate due diligence and applicable legal and regulatory requirements.
A venture thesis links a material customer problem to a differentiated product, a credible route to distribution and economics that can improve with scale.
Retention by customer cohort; ARR, net revenue retention and gross revenue retention; Gross margin and contribution margin.
Product-market fit does not develop; Funding gap or excessive dilution; Founder or key-person dependency.
Venture investments are typically illiquid and may require multiple years and additional financings before a sale is possible.
Venture capital finances young companies whose products or business models may scale rapidly but remain uncertain. At seed and early stages, evidence may centre on a validated customer problem, a working product and early adoption; later rounds require stronger proof of retention, repeatable acquisition and operating economics. The company may need several financing rounds before it generates positive cash flow, so runway, milestone funding and dilution are integral to the thesis. A large addressable market is not sufficient: customers must adopt and pay, and the company must retain a meaningful share of the value it creates. Venture shares are illiquid and outcomes are highly dispersed. Investors evaluate both the potential scale of a successful company and the probability and consequences of failure. Company stage is not determined by a round label alone: commercial evidence, product maturity, financing needs and governance readiness vary materially between businesses. Early-stage valuations rely more heavily on milestone progress and scenario analysis, while later-stage businesses may support deeper cohort, margin and cash-conversion analysis. In either case, ownership must be calculated on a fully diluted basis.
A venture thesis links a material customer problem to a differentiated product, a credible route to distribution and economics that can improve with scale. Diligence examines how users discover, adopt and continue using the product; whether the buyer has budget authority; and what evidence supports willingness to pay. Cohort retention and expansion help distinguish durable product value from promotional acquisition. Gross margin should account for hosting, fulfilment, support and implementation costs. Customer acquisition cost and payback are meaningful only when calculated consistently and compared with observed retention, not optimistic lifetime assumptions. The financing plan should identify milestones that reduce uncertainty, the capital needed to reach them and likely dilution through future rounds. Preferred shares can allocate governance and downside rights differently from ordinary equity. Convertible notes and SAFE-style agreements defer pricing but create conversion and dilution outcomes that must be modelled; SAFE forms are jurisdiction-specific and are not debt by default. Follow-on decisions should depend on evidence and portfolio-level capital capacity, not on sunk cost. A successful outcome can still be diluted or delayed; loss of the entire investment is possible. Valuation methods should reflect the stage and available evidence. A priced round offers a negotiated reference point but may contain preferences or rights that make headline valuation an incomplete measure of common-equity value. Scenario methods can test plausible company outcomes, financing needs and dilution. Portfolio construction also matters: early-stage outcomes are uneven, and an individual successful company may not offset concentration or follow-on decisions made without disciplined capital allocation.
Finance product development, initial hiring and early customer validation. Key evidence includes a specific problem, credible founder-market fit, prototype quality and a focused test plan.
Back a company converting product-market evidence into repeatable distribution. Examine cohort retention, sales efficiency, gross margin and the management systems required to scale.
Fund expansion where revenue quality and unit economics are increasingly observable. Growth should be assessed alongside cash burn, governance readiness and a realistic path to self-funding or exit.
Support research-led or technically complex products with longer validation cycles. Assess intellectual-property ownership, technical milestones, capital intensity and customer qualification timelines.
Instrument selection connects economic exposure with ownership rights, cash-flow priorities and the capital structure. Transaction terms and legal requirements determine the appropriate form.
Often used in priced financing rounds. Liquidation preferences, conversion, voting, anti-dilution and participation terms affect outcomes across exit values and must be read as a complete package.
Debt instruments that may convert into equity under defined events. Interest, maturity, discount, valuation cap, seniority and repayment provisions determine exposure if conversion is delayed or fails.
Contractual rights to future equity, typically without interest or a maturity date in standard YC forms. Conversion mechanics and legal treatment vary; use requires jurisdiction-specific documentation and advice.
Rights may allow participation in later rounds to maintain ownership. Model reserve needs and future dilution rather than assuming the initial stake remains constant.
Metrics should be defined consistently, reconciled to source records and tested under downside assumptions.
Focus development on a defined use case, customer feedback and demonstrable outcomes rather than feature volume.
Test buyer segments, sales channels, onboarding and pricing to identify a replicable acquisition motion.
Build finance, security, hiring and reporting capabilities at a pace aligned with complexity and customer expectations.
Tie additional funding to specific evidence of customer value, retention, unit economics or technical de-risking.
Venture investments are typically illiquid and may require multiple years and additional financings before a sale is possible. A strategic acquisition, secondary sale or public listing may provide liquidity, but none is assured; transfer restrictions and shareholder rights can limit timing. Model the possibility of no exit, a down round, further dilution or a long period without liquidity. Follow-on capital should be weighed against other opportunities and the company’s progress, not committed automatically.
Any exit route is an analytical scenario, not a promised outcome. Actual timing and proceeds depend on the asset, ownership rights, market conditions and execution.